0051 CIRCADIAN NEUROHORMONE EXCRETION AND OBJECTIVE SLEEP MEASURES IN TODDLERS PRENATALLY EXPOSED TO MATERNAL DEPRESSION AND ANTIDEPRESSANT MEDICATION
Mattera J, Miller-Loncar C, Anderson G, Johnsen D, Salisbury A. 0051 CIRCADIAN NEUROHORMONE EXCRETION AND OBJECTIVE SLEEP MEASURES IN TODDLERS PRENATALLY EXPOSED TO MATERNAL DEPRESSION AND ANTIDEPRESSANT MEDICATION. Sleep 2017, 40: a20-a20. DOI: 10.1093/sleepj/zsx050.050.Peer-Reviewed Original ResearchSerotonin reuptake inhibitorsSleep onset latencySerotonin reuptake inhibitor groupLonger sleep onset latencyMaternal depressionPrenatal exposure to maternal depressionDEP groupSerotonin reuptake inhibitor treatmentExposure to maternal depressionREM sleepPrenatal SRI exposurePrenatal maternal depressionShorter sleep onset latencyAssociated with disrupted circadian rhythmsPrenatal exposureHigher cortisol levelsEffects of prenatal exposureReuptake inhibitorsPsychiatric diagnosisBehavioral arousalDaytime cortisolDisrupted sleep architectureGroup statusTrained ratersNighttime cortisol
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply